I have always thought of writer’s block as not being able to come up with anything to talk about. BOY was I wrong!! I have so many things I could write about, yet today I had a bout of writer’s block.
My close friend, Emma, over at Trans-Advent told me “write about anything except the things you’re having a block about”… ok… “What do I write about, then?” I thought….And thought… all I could come up with were the topics I wanted to tell you all about. It became a bad cycle of “I’ll write about this….” and getting flummoxed by the swirling of all the information I wanted to impart.
Finally, my friend Bill Strait at Bill Knows What’s Up (who was having the same issues of literary constipation) suggested we pick a topic for each other. He asked me to do a commentary on recreational drug usage, specifically this article about using psilocybin for treatment of depression, and a comment or two about how I have stayed away from recreational drug usage. Challenge accepted, my friend.
First, I need to get some statistics straight in my head so I can really address this article with an informed mind. In 2001, a study of 10,000 citizens of Great Britain revealed that about 12% of their population at large had some form of psychiatric disorder. They also tested the comorbidity (two disorders at once) of psychiatric disorders and substance use and dependence. The percentage of people that had substance use or abuse that also had some form of psychiatric disorder is staggering at up to 45% of those who partake in recreational (not prescribed) drug use. An article in Psychiatric Times in 2007 offered an even more in-depth review of other studies that lead to the discussion of onset of symptoms, approaches to treatment, and prevention of relapses. Through these articles, among others, we can pretty readily confirm that people with psychiatric disorders (what I would call mental illness) have a higher instance of substance use and abuse, and thus are generally more accepting of new drugs being accessed for the purpose of treatment.
That takes me back to the article about psilocybin for depression. This article discusses a very small study placed in the scientific journal Lancet Psychiatry. As a scientist, I have a lot of problems with this article even being spread around. Let’s go over them.
This “study”, if it can even be called that, was with 12 people involved. 12 people can hardly be called even a scratch of the beginning of testing a hypothesis about mental illness. According to The Kim Foundation, it’s estimated that 26.2% of the US are diagnosed with some form of mental illness; that equates to 57 million people!! 12 people in a study only represents less than one millionth of a percent of our population. That is not a reliable study for proving or disproving anything.
Also, there was no control population for this study. This means that the people in the study could have been experiencing more of a mind-over-matter effect called a placebo effect. It is when your brain tells you something is working because you believe the treatment will work. Placebo effects can be a very good option for noninvasive treatment for some things. They are also an important thing to note in pharmaceutical research because they tell you whether the treatment is actually doing the work or the person’s belief in the treatment is what’s helping.
Again, note that this was not a randomized study AT ALL. All of the participants were volunteers and self-referred after only 2 other failed treatments. This means that no one thought “this person would be a great candidate for that study” except the participant themselves. They needed to be more open to the use of psychedelic drugs for treatment because they came into the study knowing what they’d be taking. Just the belief that hallucinogenic drugs could help them COULD have been why they felt better.
Another reason they could have felt better is just the environment that they were in during their “treatment”. All of the participants were in a dark room with a therapist to lead them through the hallucinations. Talk Therapy has been used for decades to treat depression. The power of suggestion could be called into task here as well. With a therapist present, it could be very likely that the therapist had put the idea of recovery in the participant’s head. These two possibilities are just as viable for curing depression and far more tested over the course of time.
Even with the issues that this article brings to the table about the use of the psychedelic drug psilocybin (magic mushrooms) to treat depression, it is something that our scientists may want to look into. Although anecdotal evidence shouldn’t be used to make a decision whether one should partake in a certain treatment, it’s something that could use some more organized research, discussion, and inquiry. The questions that shape a viable study of mental illness treatments come from anecdotal evidence offered by those who suffer and their families.
So, I wouldn’t recommend going out and breaking the law by taking some Magic mushrooms to treat your depression. There are lots of current treatments that are effective. That’s what can be so daunting about treating mental illness; so much of it is mired in mounds and mounds of studies that confirm or deny a treatment; no one treatment works for everyone or even a majority of sufferers.
This became a very long post, so I’m going to finish more of it tomorrow. Check back in to see more about the subject of recreational drug use and how my life has avoided becoming a statistic of abuse.